Muhammad Umar Khalid

Chief Cardiology Fellow - The Sands-Constellation Heart Institute/Rochester General Hospital.

[Muhammad Umar Khalid @umarkhalidmd]

@LuaiMadanat @ACCinTouch @JACCJournals @CorewellHealth @amrabbasmd @AhmadJabri8 @IvanHansonMD @BrianRenard1 @RBloomingdaleMD @AdamFoglesong Glad to see thinking minds. @AhmadJabri8 is the best. I have had the fortune to learn from him and being under his mentorship.

Meanwhile we did something similar. https://t.co/QmFythc2yH

Looks like it's time for some retrospective assessment or randomization.

[SCAI @SCAI]

Boon and Bane of Interventional Cardiology Call https://t.co/Js0jb9l63f

[Muhammad Umar Khalid @umarkhalidmd]

Back to the basics of Pharmacokinetics and Pharmacodynamics and how it translates to patient care.

[Behnood Bikdeli @bbikdeli]

@NatRevCardiol @SinaRsh @APSFA 🙏🙏to scholars who helped w shaping it every 👟of the way.@UjuetaFrancisco @MPfeferman76627 @MehrdadZarghami
@DJC6998 @mmonrealriete @DebSiegal @GBarnesMD @DrM_ODonoghue @MattiaGalli10 @Bweber04 @MiddeldorpS @jasonsknight @hmkyale @MitchElkind @MaryCushmanMD @GregoryPiazza4

[Behnood Bikdeli @bbikdeli]

#Antiphospholipid antibodies and #cardiovascular #thrombosis, now in @NatRevCardiol 👇:

https://t.co/JuVuLs3s16

Systematic summary across various conditions. In some cases, we challenge the old conventional thinking...

Truly multidisciplinary, led by our 🌟fellow @SinaRsh

[Journal of Invasive Cardiology @InvasiveCardiol]

🆕 Just published 🆕

Chronic Total Occlusion Percutaneous Coronary Intervention: 2026 Update

Read here 👉 https://t.co/0v3JypedDb
@esbrilakis @DLBHATTMD #cardioTwitter #cardioX #cardiology #interventionalcardiology

[Muhammad Umar Khalid @umarkhalidmd]

@2Scottish @LebenTefera @ccfvascmed @PulkitChaudhury Expedited guideline directed and expert opinion based care delivery for patients. Great step forward. We should have protocols and quality measures as well.

[Muhammad Umar Khalid @umarkhalidmd]

PERT teams should be standard of care in hospitals (Class 1). Hot off the press.
https://t.co/0MCOOdBZ5z
Congratulations @2Scottish @LebenTefera

[Dr Ihab Suliman @IhabFathiSulima]

What is the diagnosis?

[Behnood Bikdeli @bbikdeli]

🚨🚨Forgotten no more: the 🗺️burden of #Venous #Thromboembolism

Neglected for too long, it’s time to recognize the global impact of #VTE and confront the key challenges through research, clinical action, and policy change #thrombosis @JACCJournals👇

https://t.co/x2JzdU4miQ

[Society for Vascular Medicine | SVM @SVM_tweets]

Join us for #SVM Vascular Medicine Journal Club 📖 on Monday, November 17, 2025 @ 8PM ET⏰ to review HI-PRO trial evaluating the use of extended treatment of #apixaban in patients with #VTE

@mohdtarawneh95 @LaheyHospital @GregoryPiazza4 @BrighamWomens @AndrewDicksMD

[William Beaumont Hospital - Cardiology Fellowship @BeaumontCards]

👏🏽👏🏽

[Anila & Lakshmi Rao, DO @pagingdr_rao]

🚨📉 Getting Ready for Cardiology Boards?
Level up your ECG board prep with @DrByronLee who will be breaking down high-yield ECG pearls!

🗓️ Sept 30: Bradyarrhythmias, ischemia, SVTs
🗓️ Oct 7: Channelopathies, electrolyte imbalances, WCTs
🕖 7–8 pm ET

🎤 Moderated by: Anila Rao, DO
🔗Register 👉🏽 https://t.co/OLam9ZChiX

#CardioTwitter #FellowLife #ECGprep #CardiologyBoardReview @MichiganACC

[NEJM @NEJM]

Presented at #ESCCongress:

In patients with heart failure and reduced ejection fraction who were receiving guideline-directed medical therapy, digitoxin lowered the risk of death or hospitalization for heart failure as compared with placebo. Full DIGIT-HF phase 4 trial results: https://t.co/qak9UrgAhz

@escardio

[Akiva Rosenzveig @AkivaRosenzveig]

🚨New paper out: Long-Term Outcomes of Mechanical Thrombectomy vs. Catheter-Directed Thrombolysis

We found a higher risk of CTEPH with thrombectomy.

We need more data!!

Grateful to the amazing team and the mentorship of @LebenTefera.

👇Read more: https://t.co/XtMzqRruTQ

[Pam R. Taub, MD❤️💃🏻 @PamTaubMD]

Delighted to share the new 2025 AHA/ACC guidelines for the management of patients with acute coronary syndrome. Especially happy about our inclusion of aggressive lipid management with non-statins and our emphasis on the importance of cardiac rehabilitation. Thanks to @SVRaoMD and @DrM_ODonoghue for their leadership. https://t.co/mU4RC51I3y
@Drroxmehran @FaRodriguezMD @MonSangh @CMichaelGibson @rblument1 @UCSDHealth @MichaelJBlaha @DrMarthaGulati @nationallipid @CBallantyneMD @mdavidsonmd @ASPCardio @dranulala @mvaduganathan @Bweber04 @S_NarayanMD @manesh_patelMD @AHAScience @AHajduczok @EricAdler17 @EricSecemskyMD @pnatarajanmd @EugeniaGianos @mvaduganathan @JJheart_doc @DLBHATTMD @RBP0612 @noshreza @DrJMieres @MKIttlesonMD @JohnKastelein @FoodyMD @UCSDCardiology @ProfKausikRay @gabrielsteg @JamalRanaMD @rauldsf_santos @pabeda1

[The Heart @ZHeart11768530]

🔴Differential Diagnosis for a Prolonged PT and aPTT

🔸If the PT and the aPTT are both prolonged, there could be multiple factors affected in the intrinsic and extrinsic pathways or a single factor deficiency in the common pathway: FX, FV, Fll or severe fibrinogen deficiency.

[AHA Science @AHAScience]

1/ Cardiovascular diseases, including heart disease and stroke, claim more lives in the U.S. than all forms of cancer and accidental deaths – the #2 and #3 causes of death – combined.

The 2025 Statistics Update is now available.

[Muhammad Umar Khalid @umarkhalidmd]

A nice review article to start the year. https://t.co/K9WpLD31Jc